Literature DB >> 9524282

Mouse lysosomal acid lipase: characterization of the gene and analysis of promoter activity.

H Du1, M Duanmu, L R Rosa.   

Abstract

Lysosomal acid lipase (LAL) is required for the hydrolysis of intracellular cholesteryl esters and triglycerides that are delivered to lysosomes by low density lipoprotein (LDL) receptor-mediated endocytosis. To understand that the expression of LAL mRNA and protein is tissue and cell specifically regulated in mice, genomic clones for the mouse lysosomal acid lipase (mLAL) gene were isolated and characterized. The 6.8 kb of the mLAL gene 5'-flanking region was sequenced. Comparisons of mouse and human LAL genes organization revealed identical intron/exon boundaries, except for intron 1 of the mouse gene, and identical exonic length of exons 3-9. The transcription start sites and exon 1 of mLAL were characterized by 5'-RACE-PCR and S1 nuclease mapping. Transfection of 5' flanking deletions of mLAL luciferase reporter gene construct identified positive and negative regulatory elements that varied with cell type. Transfection of three progressively smaller pieces of intron 1 inserted into an SV40 promoter and luciferase reporter gene revealed an enhancer-like activity in intron 1 that is also cell type specific. These studies provide insight into the basis for regulation of this critical enzyme in lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524282     DOI: 10.1016/s0378-1119(98)00019-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature.

Authors:  Elias Badal Rashu; Anders Ellekær Junker; Karen Vagner Danielsen; Emilie Dahl; Ole Hamberg; Line Borgwardt; Vibeke Brix Christensen; Nicolai J Wewer Albrechtsen; Lise L Gluud
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

2.  Loss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans.

Authors:  Ron C Helderman; Daniel G Whitney; Madalina Duta-Mare; Alena Akhmetshina; Nemanja Vujic; Shobana Jayapalan; Jeffry S Nyman; Biswapriya B Misra; Clifford J Rosen; Michael P Czech; Dagmar Kratky; Elizabeth Rendina-Ruedy
Journal:  Bone       Date:  2021-04-07       Impact factor: 4.626

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.